AL
Alcon Inc.
ALC.SW · SIX
CHF 53.32 +0.45% (+CHF 0.24)
1M -6.81%
Market Cap $31.1B
P/E Ratio 48.53x
Div. Yield 0.53%
ROE 2.91%
Bulios Fair Price
CHF 28.81
46.0% downside
Current Price
CHF 53.32
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ALC.SW is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Strong
8/9Valuation
46 /100
Fair PEG 35.75x
P/E 48.53x
P/B 1.44x
Growth
79 /100
Growing FCF growth 56.53%
EPS growth 44.93%
Book val. growth 3.82%
Profitability
69 /100
Strong Op. margin 10.25%
Gross margin 56.83%
FCF margin 15.89%
Quality
17 /100
Poor ROA 2.05%
ROIC 3.34%
Asset turnover 0.35x
Debt
81 /100
Low Int. coverage 5.34x
Debt/Equity 0.25x
Net debt/EBITDA 1.70x
Stability
68 /100
Stable EPS volatility 107.09%
Beta 0.70x
Profitable years 5
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ALC.SW
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
David J. Endicott
Employees
25,000
Headquarters
Geneva
Upcoming events
10 NOV
Earnings
Upcoming earnings report